Related Experiment Video
Updated: Jun 16, 2026
03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
[The expression stathmin gene in laryngeal squamous cell carcinoma]
Xuecong Zhang1, Hua Cao, Dongling Gao
1Department of Otolaryngology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
Summary
Stathmin gene expression is significantly elevated in laryngeal squamous cell carcinoma (LSCC). This finding suggests stathmin may be a crucial factor in LSCC development and a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Gene Expression Analysis
Context:
- Laryngeal squamous cell carcinoma (LSCC) is a significant global health concern.
- Understanding the molecular mechanisms underlying LSCC is crucial for developing effective treatments.
- The role of stathmin gene in LSCC pathogenesis requires further investigation.
Purpose:
- To investigate the expression levels of the stathmin gene in LSCC tissues compared to normal laryngeal tissues.
- To determine the correlation between stathmin gene expression and the occurrence and development of LSCC.
Summary:
- Stathmin gene expression was assessed in 35 LSCC specimens and 18 normal laryngeal tissues using in situ hybridization.
- A high positive rate (69%) of stathmin gene expression was observed in LSCC tissues, localized in both cytoplasm and nucleus.
- Normal laryngeal tissues exhibited significantly lower stathmin gene expression, with only 6 out of 18 showing weak positive signals.
Impact:
- The study indicates that stathmin gene expression plays a pivotal role in the pathogenesis and progression of LSCC.
- Stathmin may represent a promising biomarker for LSCC diagnosis and a potential target for biotherapy in LSCC treatment.
